Status: current, Defined. Date: 31-Jan 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1371241000168118 | Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4140311000168115 | Qlaira (dienogest 3 mg + estradiol valerate 2 mg) tablet [17 tablets] (&) (dienogest 2 mg + estradiol valerate 2 mg) tablet [5 tablets] (&) (estradiol valerate 3 mg) tablet [2 tablets] (&) (estradiol valerate 1 mg) tablet [2 tablets] (&) (inert substance) tablet [2 tablets], 3 x 28 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4143401000168119 | Qlaira (dienogest 3 mg + oestradiol valerate 2 mg) tablet [17 tablets] (&) (dienogest 2 mg + oestradiol valerate 2 mg) tablet [5 tablets] (&) (oestradiol valerate 3 mg) tablet [2 tablets] (&) (oestradiol valerate 1 mg) tablet [2 tablets] (&) (inert substance) tablet [2 tablets], 3 x 28 tablets | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | has subpack | estradiol valerate 3 mg tablet [2] (&) estradiol valerate 2 mg + dienogest 2 mg tablet [5] (&) estradiol valerate 2 mg + dienogest 3 mg tablet [17] (&) estradiol valerate 1 mg tablet [2] (&) inert substance tablet [2], 28 | true | Inferred relationship | Some | 1 | |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | Is a | estradiol valerate 3 mg tablet [2] (&) estradiol valerate 2 mg + dienogest 2 mg tablet [5] (&) estradiol valerate 2 mg + dienogest 3 mg tablet [17] (&) estradiol valerate 1 mg tablet [2] (&) inert substance tablet [2], 3 x 28 | true | Inferred relationship | Some | ||
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | has TPUU | Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet | true | Inferred relationship | Some | 2 | |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | has TPUU | Qlaira (estradiol valerate 3 mg) tablet | true | Inferred relationship | Some | 3 | |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | has TPUU | Qlaira (estradiol valerate 1 mg) tablet | true | Inferred relationship | Some | 4 | |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | has TPUU | Qlaira (inert substance) tablet | true | Inferred relationship | Some | 5 | |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | has TPUU | Qlaira (estradiol valerate 2 mg + dienogest 2 mg) tablet | true | Inferred relationship | Some | 6 | |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | has TP | Qlaira | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | Is a | True | Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR